Cargando…
Biomarkers in Multiple Sclerosis: An Up-to-Date Overview
During the last decades, the effort of establishing satisfactory biomarkers for multiple sclerosis has been proven to be very difficult, due to the clinical and pathophysiological complexities of the disease. Recent knowledge acquired in the domains of genomics-immunogenetics and neuroimmunology, as...
Autores principales: | Katsavos, Serafeim, Anagnostouli, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564381/ https://www.ncbi.nlm.nih.gov/pubmed/23401777 http://dx.doi.org/10.1155/2013/340508 |
Ejemplares similares
-
Determinants of stigma in a cohort of hellenic patients suffering from multiple sclerosis: a cross-sectional study
por: Anagnostouli, Maria, et al.
Publicado: (2016) -
First-line disease modifying treatments in pediatric-onset multiple sclerosis in Greece: therapy initiation at more advanced age is the main cause of treatment failure, in a retrospective observational study, with a cohort from a single Multiple Sclerosis Center
por: Skarlis, Charalampos, et al.
Publicado: (2022) -
HLA-DPB1*03 as Risk Allele and HLA-DPB1*04 as Protective Allele for Both Early- and Adult-Onset Multiple Sclerosis in a Hellenic Cohort
por: Anagnostouli, Maria, et al.
Publicado: (2020) -
Body Fluid Biomarkers for Alzheimer’s Disease—An Up-To-Date Overview
por: Bălașa, Adrian Florian, et al.
Publicado: (2020) -
Neuronanomedicine: An Up-to-Date Overview
por: Teleanu, Daniel Mihai, et al.
Publicado: (2019)